Treatment with donidalorsen to prevent swelling attacks led to fewer of them and gains in quality of life for adults and…
Articles by Lindsey Shapiro, PhD
KalVista Pharmaceuticals plans to submit an application to the U.S. Food and Drug Administration (FDA) in June seeking approval of…
The investigational therapy donidalorsen was well tolerated and significantly reduced the rate of swelling attacks in hereditary angioedema (HAE)…
Preventive treatment with Orladeyo (berotralstat) was associated with improved treatment satisfaction among hereditary angioedema (HAE) patients who had…
The Institut national d’excellence en santé et services sociaux (INESSS) has recommended that BioCryst Pharmaceuticals’ Orladeyo (berotralstat) be reimbursed…
A significant proportion of people diagnosed with drug-induced angioedema due to using certain blood pressure medications — namely angiotensin-converting…
Changes in the properties of endothelial cells that line blood vessels may underlie increases in the numbers of circulating immune…
The Phase 3 clinical trial of oral sebetralstat as an on-demand treatment for swelling attacks in people with…
Authorities in Chile have approved Orladeyo (berotralstat) to prevent swelling attacks in hereditary angioedema (HAE) patients 12 and…
Insurance issues significantly affected the physical, psychological, and financial health of people with hereditary angioedema (HAE) in the U.S.,…